ENLIVEX THERAPEUTICS LTD (ENLV) Stock Balance Sheet
NASDAQ:ENLV - Nasdaq - IL0011319527 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 2.12M | 1.20M | N/A | |||
| Cash Equivalents | 1.04M | 0.00 | 47.82M | 10.00M | 5.67M | |||
| Marketable Securities | 20.20M | 26.51M | 300.00K | 72.93M | 30.03M | |||
| Receivables | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 2.50M | 6.44M | 2.09M | 2.31M | 2.41M | |||
| Total Current Assets | 25.99M | 33.76M | 52.33M | 86.44M | 38.12M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.15M | 2.58M | 14.90M | 8.22M | 2.14M | |||
| Other Non-Current Assets | 541.00K | 487.00K | 410.00K | 490.00K | 100.00K | |||
| Total Non-Current Assets | 1.69M | 3.07M | 15.31M | 8.71M | 2.24M | |||
| TOTAL ASSETS | 27.69M | 36.83M | 67.64M | 95.15M | 40.36M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | N/A | N/A | |||
| Accrued Expenses | 2.85M | 4.00M | 4.66M | 3.73M | 2.74M | |||
| Accounts Payable | 811.00K | 827.00K | 1.95M | 880.00K | 460.00K | |||
| Other Current Liabilities | 142.00K | 1.23M | N/A | 110.00K | 1.17M | |||
| Total Current Liabilities | 3.80M | 6.06M | 6.61M | 4.72M | 4.37M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 299.00K | 686.00K | 4.19M | 5.39M | 500.00K | |||
| Total Non-Current Liabilities | 299.00K | 686.00K | 4.19M | 5.39M | 500.00K | |||
| TOTAL LIABILITIES | 4.10M | 6.75M | 10.80M | 10.11M | 4.87M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -127.11M | -112.09M | -83.03M | -51.97M | -37.50M | |||
| Additional Paid In Capital | 146.91M | 138.94M | 136.65M | 133.80M | 70.36M | |||
| Common Shares | 2.69M | 2.14M | 2.12M | 2.11M | 1.65M | |||
| Other Shareholders' Equity | 1.10M | 1.10M | 1.10M | 1.10M | 980.00K | |||
| Shares Outstanding | 23.65M | 18.60M | 18.42M | 18.33M | 14.59M | |||
| Tangible Book Value per Share | 1.00 | 1.62 | 3.09 | 4.64 | 2.43 | |||
| Total Shareholders' Equity | 23.59M | 30.08M | 56.84M | 85.04M | 35.49M | |||
| TOTAL LIABILITIES AND EQUITY | 27.69M | 36.83M | 67.64M | 95.15M | 40.36M | |||
| Statistics | ||||||||
| Current Ratio | 6.84 | 5.57 | 7.92 | 18.31 | 8.72 | |||
| Return On Assets (ROA) | -54.23% | -78.92% | -45.92% | -15.21% | -29.29% | |||
| Return On Equity (ROE) | -63.65% | -96.62% | -54.64% | -17.02% | -33.31% | |||
All data in USD , ROIC based on taxRate of 0.21